Meningeal Neoplasms

CHAPTER 30 Meningeal Neoplasms

The meningeal coverings of the human brain are composed of three distinct anatomic structures, each of which has two component layers.

The outermost and thickest layer is the dura mater (L. “tough mother”), which is composed of an outer layer, which functions as the periosteum of the inner table of the calvaria, and the deeper meningeal layer. This deeper layer infolds and forms the walls of the dural sinuses and the dural reflections of the brain compartments such as the falx cerebri, the tentorium cerebelli, and the diaphragma sella. This deeper meningeal layer also infolds to form a number of smaller canals and compartments including Meckel’s cave, which houses the trigeminal or semilunar ganglion, and Dorello’s canal, which allows passage of the sixth cranial nerve from the cisternal space to the lateral wall of the cavernous sinus. The cavernous sinus is a complex venous labyrinth in the lateral parasellar region formed from reflections of the inner layer of the dura. Similarly, the optic sheath is a cylindrical structure surrounding and protecting the optic nerves. The internal auditory canal is lined by this inner meningeal layer of dura as well.

The innermost layers, the pia mater and the arachnoid (Gr. “spider-like”), are relatively thin and are referred to collectively as the leptomeninges (Gr. lepto, “thin”).

The arachnoid, which coats the inner surface of the dura, is also composed of two layers: the more superficial or arachnoid cap layer and the deeper arachnoid trabecular layer. These layers vary in thickness in different regions of the brain. The pia mater, which is innermost and immediately covers the brain, is composed of two layers: the epipia and the intima pia. Between the arachnoid and the pia is the subarachnoid space, which is filled with cerebrospinal fluid and is variable in size, enlarging to form the subarachnoid cisternal spaces at the base of the brain and narrowing over the cerebral convexities.1

The embryology of the meninges is a subject of ongoing study, with some believing that the dura mater is of mesodermal origin and that the leptomeninges are of ectodermal origin.2 Comparative studies in birds show that the leptomeninges are at least partially of neural crest origin.3,4 In any case, meningeal tissues and the neoplasms they give rise to are capable of exhibiting a wide range of mesodermal, ectodermal, and even neuroectodermal characteristics.

The term meningeal neoplasms, therefore, encompasses a broad group of extra-axial intracranial neoplasms that arise from any of the meningeal coverings of the brain:


In 1922, Harvey Cushing introduced the term meningioma to refer to a disparate group of intracranial, extra-axial neoplasms, which had been previously referred to by many different names, most commonly dural endotheliomata. Sixteen years later, Dr. Cushing and Dr. Louise Eisenhardt solidified the diagnostic nomenclature with their monograph entitled Meningiomas. They described their experience with 313 tumors, codifying 22 different histologic subtypes of this tumor, and providing convincing clinical and pathologic evidence that these different tumors were all variants of a single entity.5

Despite subsequent advances, particularly in the fields of molecular biology, much of their work has withstood the test of time. The generally accepted cell of origin of meningioma is the arachnoid cap cell, which is found in the most superficial layer of the arachnoid tissues. The arachnoid origin was first suggested by Bright in 1831,5 then more conclusively demonstrated by Cleland in 1864.5 In 1902, Schmidt5 pursued a more detailed dissection, allowing the observation that these tumors arose from the most superficial layer of the arachnoid or, according to current terminology, the arachnoid cap cells. Arachnoid cap cells are most commonly found on the surface of the brain in association with dural sinuses and dural reflections but are also present in the tela choroidea, which extends throughout the ventricular system of the cerebrum. The arachnoid component of the tela choroidea gives rise to the less common intraventricular meningioma. Rarely, meningiomas are found elsewhere in the body, including intraosseous, intracerebral nondural,6 and pulmonary locations.7 The histogenesis of these tumors is uncertain; however, it is hypothesized that these distant or ectopic meningiomas may arise from arachnoid tissue associated with nerve sheaths or from ectopic meningothelial cells or possibly from pluripotential stem cells.


Meningiomas are one of the most common intracranial neoplasms, representing approximately 25% of all new brain tumor diagnoses per year.8 There is roughly a 1.5 to 2.0 female-to-male ratio, and the peak age at diagnosis is 60 to 70 for men and 70 to 80 for women. Interestingly, the female preponderance is not present in atypical and pediatric meningiomas but is increased to 8 to 10:1 in spinal meningiomas. Female preponderance is also lacking in Africans and African Americans, who, as a group, have a slightly higher incidence of meningiomas than persons of either European or Asian descent.9,10 Incidence values vary in different studies, but a large meta-analysis gives the figure of 2.6 per 100,000 overall, and this is increased to 3.1 per 100,000 in those of African heritage.11

Meningiomas may be subdivided into many different categories according to histology, location, degree of biologic aggressivity, morphology, and demographic features. The classification scheme that has the most clinical relevance in terms of treatment, prognosis, and natural history is that adopted by the World Health Organization (WHO) in its 2007 revision of brain tumor taxonomy,12 which divides meningiomas into three categories: benign, atypical, and malignant or anaplastic.

Benign—WHO grade I: 80% to 90%

Atypical—WHO grade II: 8% to 10%

Malignant—WHO grade III: 1% to 2%

The 22 histologic subtypes initially proposed by Cushing and Eisenhardt have coalesced into 13 that have been incorporated into the WHO category, as just noted. In addition to the 4 atypical subtypes in WHO grade II (clear cell and chordoid) and grade III (papillary and rhabdoid), there are 9 other distinct histologic patterns recognized by WHO 2007; several of these also exhibit distinct imaging features. Varying degrees and admixtures are also seen, as well as other variations that are not judged to represent distinct subtypes at this point. In addition to histologic variations, meningiomas may also be differentiated by gross morphology. Most meningiomas assume a rounded morphology indicative of a radial growth pattern, but a small subset of meningiomas exhibits a flattened or en plaque morphology.

Neither WHO grade nor histologic subtype is the sole determinant of clinical outcome. Location and size at presentation are also important factors. Meningiomas occur most commonly in the parasagittal region (25%), followed by high convexities (19%); sphenoid ridge (17%); suprasellar, posterior fossa, and olfactory groove (each 8% to 9%); middle fossa/Meckel’s cave; tentorial, and peritorcular regions (each 3% to 4%); and intraventricular, foramen magnum, and optic sheath (each 1%).

In addition to its effect on both neurologic symptoms and surgical therapy, there is evidence that meningiomas arising in different locations represent distinct subtypes, which may exhibit different demographics and different underlying genetic etiology. One example is the greater tendency to manifest perilesional edema associated with frontotemporal and occipital meningiomas. An example of demographic differences based on location is the high percentage of female patients with meningiomas overlying the greater sphenoid wing.

The age of the patient is also important. Some data suggest that meningiomas arising in younger individuals are more aggressive, although definitive statistical evidence has not been collected.1315

Even grade I meningiomas frequently invade adjacent soft tissues and bone (but not brain and generally not arterial walls). Invasion makes complete resection more difficult and predisposes to local recurrence. Invasion of dural sinuses, such as the superior sagittal sinus, is a significant negative prognostic feature, even if the tumor is histologically grade I. En plaque morphology is usually associated with grade I histology and is typically seen in the skull base, sphenoid, and orbital regions. Surgically, curative local resection is more difficult to achieve with en plaque tumors; and therefore they have a greater tendency to recur.


The genetic basis for meningiomas is currently under intensive ongoing study.18 As in many other neoplasms, meningiomas are believed to arise by a multi-hit mechanism of genetic damage or abnormality, possibly involving damage or absence of a suppressor gene, as well as amplification or abnormality of an active pro-oncogene.19 The most common genetic abnormality associated with meningioma is that found on chromosome 22q12, which is implicated in neurofibromatosis type 2 (NF2). Meningiomas are part of the NF2 syndrome, which is associated with multiple inherited schwannomas, meningiomas, and ependymomas, giving rise to the mnemonic MISME, pronounced “miss me.” NF2 is associated with abnormal gene function at chromosome 22q12, which codes for a protein named merlin or schwannomin. Merlin’s function is still under study, but it is believed to regulate cell-cell contact inhibition and also to play a role in cell morphology. Inactivation would therefore result in cells with altered morphology and impaired contact inhibition. NF2 mutations are seen in patients with NF2 and also in more than half of patients with sporadic meningiomas. It has also been shown that other chromosome 22 mutations distinct from the NF2 locus are common in meningiomas, suggesting that there may be another tumor suppressor locus on chromosome 22 distinct from that which encodes for merlin.20,21 Some data suggest that different subpopulations of meningiomas based both on histology (transitional and fibrous) and location (anterior skull base) may be more likely to show merlin inactivation than others. Meningothelial tumors only rarely show reduced expression of merlin, and radiation-induced meningiomas also are associated with decreased likelihood of chromosome 22q12 abnormalities but are more likely to display structural abnormalities of chromosome 1p.

Chromosomal and genetic abnormalities that have been found in patients with meningiomas and particularly in patients with higher grade II and grade III meningiomas include dicentric or ring chromosomes, absence or alterations in 1p, 3p, 6q, 9p, 10q,22 and 14q23, and amplifications in 17q and 20q. These abnormalities may be associated both with origination of the meningothelial neoplasm and possibly also progression in grade.

Other specific genetic changes associated with atypical (grade II) and malignant or anaplastic (grade III) meningiomas include expression of the enzyme telomerase, which allows cells to maintain telomere length over multiple cell division cycles.24 Proteins associated with increased angiogenesis, including tenascin and vascular endothelial growth factor, are also found in higher-grade meningiomas. In one group, 25% of malignant meningiomas showed deletions of the CDKN2A locus on chromosome 9p21. Other specific findings include the loss of the NDRG2 gene on chromosome 14q11.2 and the gain of the RPS6KB1 gene on chromosome 17q23 (Fig. 30-1).

It is fair to say that although many genetic findings associated with meningioma origination and progression to higher grade have been discovered, further work and study is expected to broaden our understanding of the developmental pathways of these tumors.

Meningiomas express a wide variety of cell surface proteins and receptors, including hormonal receptors.25 Vimentin is virtually always present, and epithelial membrane antigen (EMA) reactivity is seen in the majority of cases. EMA is somewhat more specific than vimentin, which is generally diffusely positive but nonspecific. Claudin-1 may be useful in addition to EMA for ambiguous cases.

The role of hormonal receptors in meningioma growth is complex and not fully understood. Estrogen, progesterone, and androgen receptors may be found in meningiomas. Immunopositivity for progesterone is by far more common than other hormone receptors.26 Progesterone receptors have been shown to stimulate meningeal cell growth in vitro culture, and progesterone receptor inhibitors have been shown to have the opposite effect. In addition, the extent of progesterone receptor expression appears to be inversely proportional to tumor grade and proliferation.27 Accordingly, benign tumors are more likely to express immunoreactivity to progesterone receptor antigens (50% to 80%). Estrogen receptors are somewhat less commonly expressed than progesterone receptors. The relationship between gender and hormonal receptor status remains an area of ongoing study.28

Other immunohistochemical markers seen in meningiomas include somatostatin, prolactin, and growth hormone receptors. Overall, there is no specific marker or pattern of markers that is universally diagnostic of meningothelial neoplasms.



The great majority (80% to 90%) of meningiomas are grade I, and this figure may be higher if small asymptomatic tumors are included. The majority of these tumors display typical meningothelial histology without metaplastic or other atypical features. Typical imaging features consist of a rounded, smooth and well-circumscribed extra-axial mass that is broad based against the dural surface. These lesions show dense and homogeneous enhancement, frequently with adjacent dural thickening and enhancement described as the “dural tail” (Fig. 30-6). This dural tail has been found to be reactive in most cases and may not represent extension of the neoplasm. It is suggestive but not specific for meningioma, and it is commonly seen in other dural-based tumors as well.29,30 Most common locations include the frontal convexities and the falx as well as the sphenoid wing. Other typical but less common locations include the orbital sheath, the tentorium cerebelli, the petroclinoid ligaments, the cavernous sinuses, and the olfactory grooves (Fig. 30-7).

If any of several less common histologic variants are present, the MRI signal characteristics may vary, following water (Fig. 30-8), fat, or bone signal intensity. Central sand-like or psammomatous calcification is relatively common and will be hypointense on MRI (Fig. 30-9). Markedly prominent vascularity in an otherwise benign meningioma may be designated as an angiomatous meningioma (Fig. 30-10).

Morphologic variations range from rounded to flattened, or en plaque, configurations. Perilesional edema may be present to varying degrees, and some studies suggest that this is more common in frontal than occipital tumors. Although present in all three grades, perilesional edema may be somewhat more common and more exuberant in higher-grade tumors and may be associated with increased likelihood of local recurrence after surgical resection (Fig. 30-11).

Meningioma location is usually dural based but may also be intraventricular, usually in the atrium of the lateral ventricles. Intraventricular meningiomas are most commonly typical grade I benign lesions (Fig. 30-12) but may occasionally be atypical grade II (Fig. 30-13) or even malignant grade III lesions.

Atypical (grade II) meningiomas, such as clear cell (Fig. 30-14) and chordoid (Fig. 30-15) subtypes, or malignant (grade III) meningiomas, including subtypes papillary (Fig. 30-16) and rhabdoid (Fig. 30-17), may be indistinguishable from “vanilla” or grade I tumors. Not uncommonly, however, they may display greater irregularity in margins and in overall morphology and may be seen to invade brain parenchyma. Florid perilesional edema is somewhat more common in higher-grade meningiomas as well. Atypical imaging features do sometimes but not invariably follow atypical histologic patterns.

Jan 22, 2016 | Posted by in NEUROLOGICAL IMAGING | Comments Off on Meningeal Neoplasms

Full access? Get Clinical Tree

Get Clinical Tree app for offline access